BFC Planning »

SPDR S&P Pharmaceuticals shares owned by BFC Planning

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by BFC Planning from 13F filings

Historical chart of BFC Planning investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by BFC Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by BFC Planning

Quarter filed Position value Share count Share price at filing
2026-06-30 $32k 489 66.27
2026-03-31 $32k 589 54.17
2025-12-31 $37k 655 55.97
2025-09-30 $29k 611 47.92

More positions owned by BFC Planning

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust ST STR PR SP1500 (SPTM)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)

View all positions for BFC Planning

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Parkway Wealth Management Group
Kingsview Wealth Management
Envestnet Asset Management
Envestnet Portfolio Solutions
First Citizens Bank & Trust
LPL Financial
Branch Banking & Trust Company
Measured Wealth Private Client Group
Private Advisor
UBS Group
Susquehanna International
Cetera Investment Advisers
Wharton Business Group

View all funds holding SPDR S&P Pharmaceuticals